Get started
Author

Vian Amber

Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males
2005 · Waljit S. Dhillo, Owais B. Chaudhri, et al. · The Journal of Clinical Endocrinology & Metabolism · 656
Kisspeptin-54 Stimulates Gonadotropin Release Most Potently during the Preovulatory Phase of the Menstrual Cycle in Women
2007 · Waljit S. Dhillo, Owais B. Chaudhri, et al. · The Journal of Clinical Endocrinology & Metabolism · 294
PYY3–36 and Oxyntomodulin Can Be Additive in Their Effect on Food Intake in Overweight and Obese Humans
2010 · Benjamin C.T. Field, Alison M. Wren, et al. · Diabetes · 112
PDF
Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy
2009 · Hector C. Keun, Jasmin Sidhu, et al. · Clinical Cancer Research · 65
Kisspeptin‐54 at high doses acutely induces testicular degeneration in adult male rats via central mechanisms
2009 · EL Thompson, V Amber, et al. · British Journal of Pharmacology · 46
PDF
Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial
2023 · Stephan A Grupp, Selim Corbacioglu, et al. · The Lancet Haematology · 43
Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males
2006 · Waljit S. Dhillo, Owais B. Chaudhri, et al. · Obstetrical & Gynecological Survey · 42
Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: Relation to liver, muscle and regional body fat content
2007 · E. Louise Thomas, Elizabeth Potter, et al. · Atherosclerosis · 27
A phase 2 trial of defibrotide for the prevention of chimeric antigen receptor T-cell–associated neurotoxicity syndrome
2023 · Caron A. Jacobson, Allison C. Rosenthal, et al. · Blood Advances · 24
PDF
A multicentre, multinational, prospective, observational registry study of defibrotide in patients diagnosed with veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: an EBMT study
2021 · Mohamad Mohty, Marta Lisa Battista, et al. · Bone Marrow Transplantation · 21
Total Lipid Management and Cardiovascular Disease in the Dyslipidemia International Study
2013 · Jean Ferrières, Vian Amber, et al. · Cardiology · 17
Impact of lipid‐lowering therapy on the prevalence of dyslipidaemia in patients at high‐risk of cardiovascular events in UK primary care – a retrospective database study
2013 · K. Jameson, V. Amber, et al. · International Journal of Clinical Practice · 12
PDF
Usage of troponin in the real world: a lesson for the introduction of biochemical assays
2005 · K. Rajappan, E. Murphy, et al. · QJM · 10
A Phase 3, Randomized, Adaptive Study of Defibrotide (DF) Vs Best Supportive Care (BSC) for the Prevention of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) in Patients (pts) Undergoing Hematopoietic Cell Transplantation (HCT): Preliminary Results
2021 · Stephan A. Grupp, Selim Corbacioglu, et al. · Blood · 9
Burden of illness of non-hematopoietic stem cell transplant-related hepatic sinusoidal obstruction syndrome: A systematic review
2024 · Lin Fan, Fiona Stewart, et al. · Heliyon · 4
Verification of the Prediction Accuracy of a Biomarker-Based Prognostic for Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) After Hematopoietic Cell Transplantation (HCT)
2024 · Santosh Putta, Bradford Young, et al. · Transplantation and Cellular Therapy · 4
Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Following Hematopoietic Stem Cell Transplantation or Chemotherapy--Results from the Italian Therapeutic Use Protocol
2015 · Franco Locatelli, Maura Faraci, et al. · Blood · 4
Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome without Hematopoietic Cell Transplantation in a Real-World Population in the United States: Patient Characteristics, Prior Treatment Patterns, and Time to Diagnosis
2021 · Xue Wang, Bouchra Benettaib, et al. · Blood · 3
New Biomarkers in Breast Cancer: microRNAs and Leptins – Where Are We Now?
2007 · Tamara Keith, Vian Amber, et al. · Biomarkers in Medicine · 3
Adiposity and the Gut - The Role of Gut Hormones
2007 · Vian Amber, Stephen Bloom · Current Nutrition & Food Science · 3
Non-hematopoietic cell transplant-related veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) in solid tumor and hematologic malignancies: A systematic review.
2023 · Fiona Stewart, Kimberly Ruiz, et al. · Journal of Clinical Oncology · 2
PDF
Resolution of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) with Defibrotide Following HCT in Adult and Pediatric Patients: Pooled Analysis of Defifrance and EBMT PASS Registries
2023 · Mohamad Mohty, Franco Locatelli, et al. · Blood · 1
Time to resolution of veno-occlusive disease/sinusoidal obstruction syndrome post-HCT in defibrotide-treated adults from two European registries
2026 · Mohamad Mohty, Régis Peffault de Latour, et al. · Bone Marrow Transplantation
PDF
Abstract 470: JZP898, a conditionally activated interferon alpha, generates efficacy and robust TME engagement in syngeneic mouse models.
2026 · Ankur Karmokar, Emanuele Loro, et al. · Cancer Research
Treatment Duration, Symptom Resolution, and Survival in Defibrotide-Treated Patients (pts) with Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) By Exposure to Inotuzumab (InO) or Gemtuzumab (GO): Pooled Analysis of Defifrance and EBMT PASS Registries
2025 · Mohamad Mohty, Franco Locatelli, et al. · Transplantation and Cellular Therapy
Works count: 50
Citation count: 1,401
H-index: 12
I10-index: 13
Year
Topic
Type